Retacrit 00069-1318
Generic: Epoetin Alfa-Epbx
Product NDC
00069-1318- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- Injection, Solution
- Route
- Intravenous And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 9, 2020
- Listing Expires
- December 31, 2026
- Application
- BLA125545
Need to source Retacrit? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Epoetin | 10000 [iU]/mL |
Drug Class
Erythropoiesis-stimulating Agent [EPC]Erythropoietin [CS]Increased Erythroid Cell Production [PE]
Packaging Options(1)
10 VIAL, MULTI-DOSE in 1 CARTON (0069-1318-10) / 2 mL in 1 VIAL, MULTI-DOSE (0069-1318-01)